Bing

SEARCH HISTORY

Healthcare stocks declined broadly on Wall Street on Tuesday morning, with the sector seeing an overall decline of 0.9%. More broadly, the Dow Jones Industrial Average declined 0.8%, the Nasdaq was down 1.2% and the S&P 500 declined 0.8%. Some of …
Investor Place · 5/12/2015
Amarin (NASDAQ: AMRN ) and Arena Pharmaceuticals (NASDAQ: ARNA ) are two of the better-known biotech stocks that saw their share prices soar heading into long-awaited regulatory approvals, only to …
The Motley Fool · 5/16/2015
Growth Stocks
Shares of Arena Pharmaceuticals (NASDAQ:ARNA) have earned a consensus recommendation of “Hold” from the seven ratings firms that are currently covering the stock, Stock Ratings News reports. Two analysts have rated the stock with a sell …
Mideast Times · 5/20/2015
More from Bing News
Arena Pharmaceuticals (NASDAQ:ARNA)‘s stock had its “market perform” rating restated by research analysts at BMO Capital Markets in a report released on Thursday. They currently have a $9.00 price objective on the stock. BMO Capital Markets’ …
Ticker Report · 5/14/2015
Arena Pharmaceuticals (NASDAQ:ARNA) opened at 4.25 on Monday. Arena Pharmaceuticals has a 1-year low of $3.26 and a 1-year high of $6.72. The stock has a 50-day moving average of $4. and a 200-day moving average of $4.. The company’s …
wkrb13.com · 5/18/2015
The stock is trading below its 50-day and 200-day moving averages of $4.46 and $4.32, respectively. Moreover, shares of Arena Pharmaceuticals Inc. have an RSI of 45.30. The complete research on ARNA is available for free at: http://get.Investor-Edge.
Market Watch · 5/18/2015
Bluebird Bio Inc (BLUE)- The company’s stocks retreated 1.8 pct. Arena Pharmaceuticals (ARNA)- The company’s shares dropped 1.2 pct. Neurocrine Biosciences (NBIX)- The company’s shares declined 0.9 pct.
Fx Pips · 5/15/2015
Arena Pharmaceuticals (NASDAQ: ARNA) this week reported first-quarter financial results ... Don't be too late to the party -- click here for one stock to own when the Web goes dark. Todd Campbell has no position in …
Investopedia · 5/13/2015
In contrast, Belviq from Arena (NASDAQ:ARNA) saw sales dip 1% on just under 14,700 bottles ... Unfortunately, even a partnership announcement will not allow a full recovery of the stock to the levels it was at just a …
Seeking Alpha · BySpencer Osborne · 1 day ago
Noranda Aluminum (NYSE: NOR) 22.7% LOWER; announced the commencement of a secondary public offering of 22,840,000 shares of the Company’s common stock by certain funds ... quarter of 2014 Arena …
StreetInsider · 5/12/2015